Trial NCT02978716

View at ClinicalTrials.gov 
Org. Study IDs: G1T28-04
Secondary IDs: 2016-004466-26

Last trial update was posted on 2022-03-23

MeSH Interventions

Carboplatin Gemcitabine

MeSH Conditions

Breast Neoplasms Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Breast Cancer Breast Neoplasm Triple-Negative Breast Cancer Triple-Negative Breast Neoplasms

Stopping Reasons

Primary Analysis and survival follow up completed per protocol. Not stopped due to safety concerns

Limitations And Caveats

Limitations of this study are the small sample size and open-label design. Antitumor outcomes were not the primary endpoints.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID